We evaluated the self-renewal property of the CD19−CD133+ MCL by overlaying a confluent layer of irradiated MS-5 cells with 1×105 MCL cells (bulk or CD133−) or 1×103 CD133+ cells (100-fold fewer cells than used in the bulk and CD133− cultures). The gene discussed is PROM1; the disease is mantle cell lymphoma.